Cite
HARVARD Citation
Yu, Y. et al. (n.d.). 71P Real-world treatment patterns and clinical outcomes for patients who received sintilimab (Sint) in first-line treatment of advanced non-small cell lung cancer (NSCLC) in China: A multicenter retrospective observational study. Immuno-oncology technology. p. . [Online].